title: Risperidone-induced hepatotoxicity in a patient addicted to synthetic cannabinoid.
authors.affiliation: aDepartment of Internal Medicine and Gastroenterology bPsychiatry Clinic, Ankara Research and Education Hospital, Ankara, Turkey.
authors.forename: Osman
authors.initials: O
authors.lastname: Saglam
authors.forename: Remzi
authors.initials: R
authors.lastname: Bahsi
authors.forename: Yasemin
authors.initials: Y
authors.lastname: Akkoca
authors.forename: Levent
authors.initials: L
authors.lastname: Filik
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002186:Cannabinoids / Q000009:adverse effects* / Q000138:chemical synthesis; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D057915:Drug Substitution; D006801:Humans; D008297:Male; D000068882:Paliperidone Palmitate / Q000627:therapeutic use; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D019966:Substance-Related Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology
chemical_list: D014150:Antipsychotic Agents; D002186:Cannabinoids; D018967:Risperidone; D000068882:Paliperidone Palmitate